This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
The below stocks have been identified as having potential to register bigger than normal share price moves (up or down) today based on the news cited
WM Morrison (MRW.L) – Posts a sharp fall in L-f-L sales excluding fuel dropped 5.6% in the six weeks to Jan. 5. Including fuel, the drop was 7.1%. It said it now expected its full-year underlying profit performance to be towards the bottom of the range of £783-853m expected. Closing Price 254.20p (Reuters)
Ted Baker (TED.L) – Announced an 18.3% increase in retail sales. Gross margins were in line with expectations. Profit before taxation for the year ending 25 January 2014 will be in line with its expectations. Closing Price 2300p (Reuters)
RSA Insurance (RSA.L) – Said it needed to boost capital and might cut its dividend following three profit warnings and a move to strengthen reserves at its Irish business. Analysts at Berenberg suggested the insurer could be a target for rival Aviva (AV.L). Closing Price 100.70p & 460.20p respectively (Reuters & Guardian)
Gulf Keystone Petroleum (GKP.L) – Pleased to announce the commencement of crude oil exports from the Shaikan field. Tendered cargo of between 30,000 tonnes and 33,000 tonnes of crude was trucked to Turkey in December. Current average oil sales from pf-1 stand at between 9,000 and 10,000 barrels per day. In discussions with a major international bank to assist with evaluation of near term debt financing options. Closing Price 177.50p (Reuters)
Marks & Spencer’s (MKS.L) – Clothing sales falling for a tenth consecutive quarter, though the firm avoided a formal profit warning thanks to a solid performance from food. Thursday 3Q sales of non-food products, at stores open over a year fell 2.1% vs. forecasts flat to down 1.5%. Closing Price 444.90p (Reuters)
Tesco (TSCO.L) – Sales at British stores open over a year, excluding fuel and VAT sales tax, fell 2.4% in the six weeks to Jan. 4. That compares to analyst forecasts in a range of down 0.5-2.5% and a third quarter decline of 1.5%. Closing Price 328.30p (Reuters)
GlaxoSmithKline (GSK.L) – Gains accelerated FDA approval for combination use of Mekinist and Tafinlar. Closing Price 1599.00p (Reuters).
For more information on any of these individual news items, call into the trading floor
| Stock | Code | Close | High | Low |
| Persimmon | PSN.L | -0.39% | 3.79% | -1.08% |
| Domino’s Pizza | DOM.L | 3.78% | 4.67% | 0.80% |
| Galliford Try | GFRD.L | 0.66% | 2.49% | -1.16% |
| Mothercare | MTC.L | -30.60% | -22.74% | -31.79% |
| Sainsbury | SBRY.L | -2.41% | 3.90% | -3.06% |
| Ferrexpo | FXPO.L | 0.06% | 2.11% | -1.50% |
| Lloyds Banking Group | LLOY.L | 1.56% | 2.01% | 0.22% |
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance. Prepared by Michael van Dulken, Head of Research